Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
Efinopegdutide
1 / 4
Peptide
GLP-1 / Glucagon Dual
EfinopegdutideOverview
Summary
GLP-1/glucagon agonist studied primarily for fatty liver disease.
Category
GLP-1 / Glucagon Dual
Mechanism
GLP-1/glucagon agonist studied primarily for fatty liver disease.
Effects
Top outcomes
- Fat loss70
- Inflammation70
Evidence
Emerging
Practical
Half-life
Long (days+)
Administration
subq
Risk
Legal status
research only
Safety
Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.
Try a preset